文献速递糖尿病肥胖与代谢综合征

葡萄糖参与2型糖尿病患者m6A动态调控

Glucose Is Involved in the Dynamic Regulation of m6A in Patients With Type 2 Diabetes.
PubMed 文献 · J Clin Endocrinol Metab · 2019-01-01

该研究纳入102例2型糖尿病患者和107例对照,采用质谱和定量PCR检测m6A含量及目标基因mRNA表达。结果显示患者m6A含量降低,FTO、METTL3、METTL14和WTAP mRNA表达升高,且m6A含量与这些基因表达呈负相关;FTO与血糖正相关。HepG2细胞中高糖上调FTO蛋白,对METTL3或METTL14无显著影响。

要点

  • 2型糖尿病患者m6A含量降低,FTO、METTL3、METTL14和WTAP mRNA表达升高。
  • m6A含量与METTL3、METTL14和FTO mRNA表达呈负相关,FTO与血糖正相关。
  • 高糖上调HepG2细胞FTO蛋白,对METTL3或METTL14无显著影响。

核心结论

  • 在2型糖尿病患者中,高糖增强FTO mRNA表达导致m6A含量降低;较低的m6A含量可能负责甲基转移酶的上调;FTO诱导FOXO1、G6PC和DGAT2 mRNA表达,并与糖代谢密切相关。

研究设计与样本

  • 研究纳入102例2型糖尿病患者和107例对照,采用液相色谱/电喷雾电离/串联质谱和定量PCR检测m6A含量及目标基因mRNA表达;另用12例正常空腹血糖、急诊高血糖或急诊低血糖患者及高糖处理、FTO敲除或过表达的HepG2细胞验证。

主要发现

  • 2型糖尿病患者m6A含量降低,FTO、METTL3、METTL14和WTAP mRNA表达水平升高。
  • m6A含量与METTL3、METTL14和FTO mRNA表达水平呈负相关;FTO与血清葡萄糖呈正相关。
  • HepG2细胞中高糖上调FTO蛋白,对METTL3或METTL14无显著影响。
  • 患者中FOXO1、G6PC和DGAT2 mRNA表达水平显著升高,并与FTO和血清葡萄糖呈正相关。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: N6-methyladenosine (m6A) in mRNA is the most abundant and reversible modification. However, the mechanism behind the decrease in m6A in patients with type 2 diabetes (T2D) has not yet been thoroughly investigated. OBJECTIVE: To clarify whether glucose is involved in the dynamic regulation of m6A in T2D and to identify a possible underlying mechanism. METHODS: Liquid chromatography/electrospray ionization/tandem mass spectrometry and quantitative PCR were performed to determine the m6A content and the mRNA expression of target genes in 102 patients with T2D and 107 controls. An additional 12 patients with normal fasting blood glucose, emergency hyperglycemia, or emergency hypoglycemia, as well as HepG2 cells with high-glucose treatment and FTO knockout or overexpression were used to confirm the initial observations in patients. RESULTS: In patients with T2D, the m6A content was decreased, and mRNA expression levels of FTO, METTL3, METTL14, and WTAP were increased. Interestingly, the m6A content was negatively associated with mRNA expression levels of METTL3, METTL14, and FTO. Moreover, FTO was positively correlated with serum glucose. In HepG2 cells, high glucose upregulated FTO protein, whereas it had no significant effect on METTL3 or METTL14. Additionally, mRNA expression levels of FOXO1, G6PC, and DGAT2 were significantly increased and positively correlated with FTO and serum glucose in patients. CONCLUSIONS: Our data revealed that in patients with T2D, high-glucose-enhanced FTO mRNA expression resulted in a decrease in m6A. The lower m6A content might be responsible for the upregulation of methyltransferases. Additionally, FTO induced mRNA expression of FOXO1, G6PC, and DGAT2 and was closely associated with glucose metabolism.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Yang Y, Shen F, Huang W, et al. Glucose Is Involved in the Dynamic Regulation of m6A in Patients With Type 2 Diabetes. J Clin Endocrinol Metab. 2019. PMID: 30137347. doi:10.1210/jc.2018-00619

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。